ET - EVgo's $1.05 billion loan from the U.S. Department of Energy will provide the company with capital to accelerate its deployments, grow its market share and increase its earnings before interest, ...
On Friday, TD Cowen reiterated its Buy rating on shares of Travere Therapeutics (NASDAQ:TVTX), maintaining a price target of $15.00. The firm's stance comes even as Travere announced a voluntary ...